source
- Biotech funding surge: 40 companies secure $100M+ rounds in H1 2026Endpoints News reported that 40 private biotech firms announced funding rounds of at least $100 million each in the first half of 2026. This count surpasses the number recorded for the same period…
- FDA approves Orca Bio's T cell therapy Tregzi to lower transplant complications in blood cancer patientsThe U.S. Food and Drug Administration has granted approval to Orca Bio's T cell therapy aimed at improving outcomes for patients undergoing blood cancer transplants. The therapy, named Tregzi, is…